myUpchar starts delivering Hospital Supplies for Health workers Kumar Jeetendra | April 27, 2020 Personal protective equipment (PPE) protects healthcare workers and caregivers who come in contact with COVID-19 patients again and again, and for prolonged periods. Globally, there is a shortage of this equipment as healthcare systems in many countries are under unprecedented strain because of the new coronavirus infection. Seeing the shortage of PPE equipment in several …
Let us know some facts about Coronavirus Kumar Jeetendra | April 27, 2020 It was post-dinner time on Saturday 4th April 2020; the 12th evening of lock-down in India. Mr.Madhav was sitting in front of his laptop eagerly waiting for the bell of 10 pm on Web meeting. He and his close friends Kiran, Avinash, Santosh, Suhas, Mahesh, Rajan, Seema, Kavya, Vidya, Geetanjali and Namrata from different places …
Oxford University planning to prepare the Covid-19 immunization by September Kumar Jeetendra | April 28, 2020 As the world is scrambling to build up a Covid-19 immunization, Oxford’s Jenner Institute, which got a headstart following the advancement in its clinical preliminaries, is presently trusting that initial scarcely any million dosages of the antibody could be made accessible by September – which is a long time in front of projections of when …
China lab rejects COVID-19 frame claims, yet infection roots still a secret Kumar Jeetendra | April 28, 2020 SHANGHAI Claims that the coronavirus pandemic began in a research facility in the Chinese city of Wuhan have no premise actually, the leader of the lab told Reuters, including that there were still no indisputable answers with regards to where the sickness began. Connivance scholars have guaranteed SARS-CoV-2, presently liable for in excess of 200,000 …
Medlife dispatches at-home COVID-19 testing in select urban areas Kumar Jeetendra | April 29, 2020 E-Health stage Medlife on Tuesday said it has banded together with authorize labs to dispatch at-home testings for COVID-19 in select urban communities and plans to grow it going ahead. The cost of a test is set at Rs 4,500 and will be directed by labs approved by the Indian Council of Medical Research (ICMR), …
Hydroxychloroquine to be given to Health workers treating COVID-19 patients Kumar Jeetendra | April 29, 2020 Healthcare workers associated with the treatment of coronavirus patients will be given hydroxychloroquine (HCQ) tablets as a preventive prescription, the Maharashtra government has said and given rules on the utilization of the medication. State Health secretary Pradeep Vyas in an ongoing round said the medication will be given to specialists, attendants and clinical staff engaged …
Strides Pharma creates medication to battle Covid-19 Kumar Jeetendra | April 29, 2020 Strides Pharma Science Limited, a worldwide pharmaceutical organization on Wednesday said it has created and marketed Favipiravir antiviral tablets which were discovered successful to battle Covid-19 disease. The item is a conventional variant of Avigan of Toyama Chemical, Japan. Favipiravir is an antiviral drug that was at first evolved to treat flu in Japan. In …
Serum Institute intends to deliver 6 crores doses of antibodies this year against coronavirus Kumar Jeetendra | April 30, 2020 The Serum Institute of India said on Tuesday it designs this year to deliver up to 6 crore dosages of a potential antibody against the new coronavirus that is under clinical trial in Britain. Serum, the world’s biggest producer of antibodies by volume, is mass-creating the immunization applicant created by the University of Oxford, which …
Key nose cells recognized as likely COVID-19 infection passage points Kumar Jeetendra | May 1, 2020 Two explicit cell types in the nose have been recognized as likely introductory disease points for COVID-19 coronavirus. Researchers found that challis and ciliated cells in the nose have elevated levels of the passage proteins that the COVID-19 infection uses to get into our cells. The distinguishing proof of these cells by scientists from the …
USFDA licenses emergency utilization of medication for treating COVID-19 patients Kumar Jeetendra | May 2, 2020 US controllers on Friday permitted crisis utilization of an exploratory medication that seems to help some coronavirus patients recuperate quicker. It is the primary medication appeared to help battle COVID-19, which has slaughtered in excess of 230,000 individuals around the world. The Food and Drug Administration acted after starter results from a legislature supported examination …
ICMR plans to examine whether novel coronavirus strain in India changed structure Kumar Jeetendra | May 2, 2020 The Indian Council of Medical Research (ICMR) is wanting to consider whether the novel coronavirus strain in India has experienced change while spreading inside the nation in the course of the most recent two months. As indicated by a senior researcher of the nation’s pinnacle wellbeing research body, deciding if the SARS-CoV2 strain has changed …
Roche gets U.S. FDA emergency use gesture for COVID-19 antibody test Kumar Jeetendra | May 3, 2020 Roche Holding AG got crisis use endorsement from the U.S. Food and Drug Administration (FDA) for a counter acting agent test to help decide whether individuals have ever been tainted with the coronavirus, the Swiss drugmaker said on Sunday. Governments, organizations and people are looking for such blood tests, to assist them with studying who …
